These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 16804832)

  • 21. Successful total hip replacement with sequential administration of bypassing agents in an adolescent boy with hemophilia A and high inhibitor titers.
    Kaya Z; Orhan Ö; Turanlı S; Yenicesu İ; Koçak Ü; Gürsel T
    Blood Coagul Fibrinolysis; 2017 Jul; 28(5):419-422. PubMed ID: 28079537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Recombinant activated Factor VII (Novoseven Novo Nordisk) for hemostasis in acquired Factor VIII-inhibitor hemophilia].
    Meili EO; Dazzi H; von Felten A
    Schweiz Med Wochenschr; 1995 Mar; 125(9):405-11. PubMed ID: 7892567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful major and minor surgery using factor VIII inhibitor bypassing activity in patients with haemophilia A and inhibitors.
    Lauroua P; Ferrer AM; Guérin V
    Haemophilia; 2009 Nov; 15(6):1300-7. PubMed ID: 19659794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitors in haemophilia A: current management and open issues.
    Haya S; Moret A; Cid AR; Cortina V; Casaña P; Cabrera N; Aznar JA
    Haemophilia; 2007 Dec; 13 Suppl 5():52-60. PubMed ID: 18078398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of activated prothrombin-complex concentrate (FEIBA) on joint and muscle bleeding in patients with hemophilia A and antibodies to factor VIII. A double-blind clinical trial.
    Sjamsoedin LJ; Heijnen L; Mauser-Bunschoten EP; van Geijlswijk JL; van Houwelingen H; van Asten P; Sixma JJ
    N Engl J Med; 1981 Sep; 305(13):717-21. PubMed ID: 6790990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SURgical interventions with FEIBA (SURF): international registry of surgery in haemophilia patients with inhibitory antibodies.
    Négrier C; Lienhart A; Numerof R; Stephens D; Wong WY; Baghaei F; Yee TT
    Haemophilia; 2013 May; 19(3):e143-50. PubMed ID: 23282031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activated prothrombin complex concentrate (FEIBA) treatment during surgery in patients with inhibitors to FVIII/IX: the updated Norwegian experience.
    Tjønnfjord GE
    Haemophilia; 2004 Sep; 10 Suppl 2():41-5. PubMed ID: 15385045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prophylactic treatment with activated prothrombin complex concentrate (FEIBA) reduces the frequency of bleeding episodes in paediatric patients with haemophilia A and inhibitors.
    Leissinger CA; Becton DL; Ewing NP; Valentino LA
    Haemophilia; 2007 May; 13(3):249-55. PubMed ID: 17498073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single 270 microg kg(-1)-dose rFVIIa vs. standard 90 microg kg(-1)-dose rFVIIa and APCC for home treatment of joint bleeds in haemophilia patients with inhibitors: a randomized comparison.
    Young G; Shafer FE; Rojas P; Seremetis S
    Haemophilia; 2008 Mar; 14(2):287-94. PubMed ID: 18081834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Some recent developments regarding arthropathy and inhibitors in haemophilia.
    Rodriguez-Merchan EC
    Haemophilia; 2008 Mar; 14(2):242-7. PubMed ID: 18201189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Economic evaluation of major knee surgery with recombinant activated factor VII in hemophilia patients with high titer inhibitors and advanced knee arthropathy: exploratory results via literature-based modeling.
    Ballal RD; Botteman MF; Foley I; Stephens JM; Wilke CT; Joshi AV
    Curr Med Res Opin; 2008 Mar; 24(3):753-68. PubMed ID: 18234151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy.
    Kubisz P; Plamenová I; Hollý P; Stasko J
    Med Sci Monit; 2009 Jun; 15(6):CS105-11. PubMed ID: 19488019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequential therapy with activated prothrombin complex concentrate (FEIBA) and recombinant factor VIIa in a patient with severe haemophilia A, inhibitor presence and refractory bleeding.
    Economou M; Teli A; Tzantzaroudi A; Tsatra I; Zavitsanakis A; Athanassiou-Metaxa M
    Haemophilia; 2008 Mar; 14(2):390-1. PubMed ID: 18194305
    [No Abstract]   [Full Text] [Related]  

  • 34. Factor VIII inhibitor-bypassing agents act by inducing thrombin generation and can be monitored by a thrombin generation assay.
    Turecek PL; Váradi K; Keil B; Negrier C; Berntorp E; Astermark J; Bordet JC; Morfini M; Linari S; Schwarz HP
    Pathophysiol Haemost Thromb; 2003; 33(1):16-22. PubMed ID: 12853708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strategies for inhibitor treatment and costs in the short and long term: a critical evaluation of recent clinical studies.
    Baghaipour MR; Steen Carlsson K
    Eur J Haematol; 2015 Feb; 94 Suppl 77():30-7. PubMed ID: 25560792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acquired hemophilia a: diagnosis, aetiology, clinical spectrum and treatment options.
    Shetty S; Bhave M; Ghosh K
    Autoimmun Rev; 2011 Apr; 10(6):311-6. PubMed ID: 21115138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Acquired haemophilia due to autoantibodies against factor VIII].
    von Depka Prondzinski M
    Hamostaseologie; 2003 Feb; 23(1):28-35. PubMed ID: 12567197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Acquired hemophilia: current status in Japan and immuno-biochemical features of autoantibodies to factor VIII].
    Tanaka I; Shima N
    Rinsho Ketsueki; 2005 Feb; 46(2):91-8. PubMed ID: 16447701
    [No Abstract]   [Full Text] [Related]  

  • 39. New alternatives and strategies in the treatment of inhibitors.
    Hoyer LW
    Prog Clin Biol Res; 1984; 150():367-72. PubMed ID: 6431440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experience of four UK comprehensive care centres using FEIBA® for surgeries in patients with inhibitors.
    Rangarajan S; Yee TT; Wilde J
    Haemophilia; 2011 Jan; 17(1):28-34. PubMed ID: 20642787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.